Mol Metab 46:101102 Patoulias D, Popovic DS, Stoian AP, Janez A, Sahebkar A, Rizzo M (2023) Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
Therefore, strain identification and description, production process and quality control, clinical trials and efficacy verification, safety assessment, clear labeling and instructions, and continuous monitoring and feedback mechanisms need to be further improved in the regulatory aspect of the safety of probiotics use
Where Can You Learn More
Our goal is to empower you with knowledge, ensuring you make informed decisions in partnership with healthcare professionals